74 related articles for article (PubMed ID: 32987413)
1. Rendu-Osler-Weber syndrome: dermatological approach.
Barbosa AB; Hans Filho G; Vicari CF; Medeiros MZ; Couto DV; Takita LC
An Bras Dermatol; 2015; 90(3 Suppl 1):226-8. PubMed ID: 26312724
[TBL] [Abstract][Full Text] [Related]
2. Hereditary hemorrhagic telangiectasia of liver: Pathophysiology with role of radiology in diagnosis and treatment.
Viyannan M; Balalakshmoji D; Leelakrishnan V
Indian J Radiol Imaging; 2020; 30(1):98-101. PubMed ID: 32476760
[TBL] [Abstract][Full Text] [Related]
3. [Not Available].
Haahr PD; Kjeldsen J; Poulsen MK; Kjeldsen AD; Fialla AD
Ugeskr Laeger; 2023 Mar; 185(13):. PubMed ID: 36999292
[TBL] [Abstract][Full Text] [Related]
4. Topical Propranolol Improves Epistaxis Control in Hereditary Hemorrhagic Telangiectasia (HHT): A Randomized Double-Blind Placebo-Controlled Trial.
Mei-Zahav M; Gendler Y; Bruckheimer E; Prais D; Birk E; Watad M; Goldschmidt N; Soudry E
J Clin Med; 2020 Sep; 9(10):. PubMed ID: 32998220
[TBL] [Abstract][Full Text] [Related]
5. Mental health and counseling intervention for hereditary hemorrhagic telangiectasia (HHT) during the COVID-19 pandemic: perspectives from Italy.
Marano G; Gaetani E; Gasbarrini A; Janiri L; Sani G; Mazza M;
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10225-10227. PubMed ID: 33090433
[TBL] [Abstract][Full Text] [Related]
6. Subaortic Membranes in Patients With Hereditary Hemorrhagic Telangiectasia and Liver Vascular Malformations.
Kim AS; Henderson KJ; Pawar S; Kim MJ; Punjani S; Pollak JS; Fahey JT; Garcia-Tsao G; Sugeng L; Young LH
J Am Heart Assoc; 2020 Oct; 9(20):e016197. PubMed ID: 33054561
[TBL] [Abstract][Full Text] [Related]
7. TIMolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (TIM-HHT)-A Prospective, Randomized, Double-Blind, Controlled, Cross-Over Trial.
Andorfer KEC; Zeman F; Koller M; Zeller J; Fischer R; Seebauer CT; Vielsmeier V; Bohr C; Kühnel TS
Pharmaceutics; 2022 Oct; 14(11):. PubMed ID: 36365152
[TBL] [Abstract][Full Text] [Related]
8. Multidisciplinary coordinated care of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease).
Alkhalid Y; Darji Z; Shenkar R; Clancy M; Dyamenahalli U; Awad IA;
Vasc Med; 2023 Apr; 28(2):153-165. PubMed ID: 36890671
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic Criteria and Treatment of Hereditary Hemorrhagic Telangiectasia].
Seebauer CT; Kuehnel T; Uller W; Bohr C; Andorfer KE
Laryngorhinootologie; 2020 Oct; 99(10):682-693. PubMed ID: 32987413
[TBL] [Abstract][Full Text] [Related]
10. Osler-Weber-Rendu Syndrome in Relation to Dermatology.
Orizaga-Y-Quiroga TL; Villarreal-Martínez A; Jaramillo-Moreno G; Ocampo-Candiani J
Actas Dermosifiliogr (Engl Ed); 2019 Sep; 110(7):526-532. PubMed ID: 30975431
[TBL] [Abstract][Full Text] [Related]
11. [Hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease) as an example of a rare disease relevant for oto-rhino-laryngology].
Geisthoff UW; Maune S; Schneider G
Laryngorhinootologie; 2011 Apr; 90(4):230-42; quiz 243-4. PubMed ID: 21523625
[TBL] [Abstract][Full Text] [Related]
12. Understanding hereditary hemorrhagic telangiectasia: From genetic anomalies to systemic manifestations, quality of life, and epistaxis management-Exploring the otolaryngologist's integral role.
Hayama M; Maeda Y; Obata S; Tsuda T; Takeda K; Nishida T; Inohara H
Auris Nasus Larynx; 2024 Apr; 51(2):305-312. PubMed ID: 38008660
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment of Osler's disease].
Haubner F; Kühnel T
HNO; 2018 May; 66(5):405-414. PubMed ID: 29687426
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
